Compare MCFT & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCFT | SCTX |
|---|---|---|
| Founded | 1968 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 477.1M | 536.5M |
| IPO Year | 2015 | 2026 |
| Metric | MCFT | SCTX |
|---|---|---|
| Price | $19.48 | $16.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $26.20 | ★ $57.00 |
| AVG Volume (30 Days) | 281.7K | ★ 376.6K |
| Earning Date | 11-05-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $348,903,000.00 | N/A |
| Revenue This Year | $75.59 | N/A |
| Revenue Next Year | $3.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.77 | N/A |
| 52 Week Low | $17.19 | $13.50 |
| 52 Week High | $28.44 | $39.60 |
| Indicator | MCFT | SCTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 31.81 |
| Support Level | $18.96 | N/A |
| Resistance Level | $25.84 | $26.50 |
| Average True Range (ATR) | 0.70 | 3.85 |
| MACD | 0.09 | -1.42 |
| Stochastic Oscillator | 25.37 | 13.24 |
MasterCraft Boat Holdings Inc is a designer, manufacturer, and marketer of recreational powerboats sold through five brands: MasterCraft, Crest, Balise, Chaparral, and Robalo. It manufactures and sells recreational inboard, outboard, and sterndrive boats that it believes delivers superior performance for water skiing, wakeboarding, wakesurfing, and fishing, as well as general recreational boating. In addition, it offers various accessories, including trailers and aftermarket parts. Its segments are the Performance and Wake segment, consisting of the MasterCraft brand, which produces boats at its Vonore, Tennessee facility; The Leisure segment, consisting of Crest and Balise brands, which produces pontoon boats at its Owosso, Michigan facility; and the Recreation and Sport Fishing segment.
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.